Qiagen Sciences LLC
QIAGEN makes sample extraction platforms and diagnostic testing solutions. The company produces instruments for automated clinical sample extraction, including the QIAsymphony Connect platform, along with diagnostic products for infectious disease, oncology, and other clinical applications such as QuantiFERON-TB Gold Plus, QIAstat-Dx Syndromic Testing, and therascreen Solid Tumor. The company serves discovery and translational research, diagnostics and clinical research, human identification and forensics, and next-generation sequencing markets.
Supplier designations
Self-certified by the company in its SAM.gov registration
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Qiagen Sciences LLC | Germantown | MD | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.